ethnopharmacolog
relev
leaf
alstonia
scholari
l
r
br
apocynacea
wide
use
ethicmedicin
mani
asia
africa
counti
also
record
common
tradit
chines
medicin
treatment
ill
respiratori
system
dai
peopl
aim
studi
provid
experiment
data
clinic
adapt
total
indol
alkaloid
ta
leaf
scholari
treat
postinfecti
cough
phase
ii
clinic
trial
materi
method
model
postinfecti
cough
anim
except
control
group
instil
intratrach
lipopolysaccharid
lp
follow
subsequ
exposur
cigarett
smoke
cs
min
per
day
total
day
mice
oral
given
ta
dose
mgkg
four
main
alkaloid
sch
scholaricin
epi
val
vallesamin
pic
picrinin
daili
cellular
infiltr
assess
bronchoalveolar
lavag
fluid
balf
express
creactiv
protein
crp
serum
determin
superoxid
dismutas
sod
activ
well
malondialdehyd
mda
content
serum
homogen
examin
final
histopatholog
examin
lung
assess
h
e
stain
result
administr
ta
four
major
alkaloid
respect
symptom
cough
mice
obvious
attenu
total
white
blood
cell
wbc
neutrophil
neu
amount
balf
reduc
obvious
patholog
damag
lung
also
attenu
also
signific
reduct
crp
mda
mark
improv
sod
conclus
efficaci
indol
alkaloid
postinfecti
cough
pic
shown
downregul
inflammatori
cell
cytokin
balanc
antioxid
pharmacolog
effect
ta
better
singl
indol
alkaloid
might
relat
synerg
effect
four
major
alkaloid
cough
classic
symptom
cold
divid
three
type
basi
durat
acut
cough
week
subacut
cough
week
chronic
cough
week
irwin
et
al
postinfecti
cough
pic
belong
type
subacut
cough
percentag
among
caus
induc
cough
common
repres
infect
upper
respiratori
track
gener
viral
origin
frequent
implic
picornaviru
rhinoviru
enteroviru
coronaviru
follow
adenoviru
metapneumoviru
parainfluenza
influenza
virus
respiratori
syncyti
viru
bocaviru
dicpiniga
et
al
footitt
johnston
jone
stewart
pappa
et
al
regamey
et
al
cough
common
troublesom
symptom
airway
infect
major
caus
signific
morbid
inde
mortal
may
last
sever
week
even
month
patient
jone
stewart
bring
patient
doctor
footitt
johnston
process
viru
replic
airway
includ
follow
part
viru
attach
epitheli
cell
cell
membran
fusion
releas
viral
nucleocapsid
protein
cell
cytoplasm
jackson
johnston
mediat
come
airway
epitheli
cell
activ
immun
respons
promot
recruit
activ
leukocyt
neutrophil
mast
cell
monocyt
lymphocyt
cell
nk
provid
effect
respons
differ
infect
furthermor
cell
releas
cytokin
chemokin
proteas
oxygen
free
radic
aggrav
injuri
airway
structur
caus
viru
biagioli
et
al
jackson
johnston
rossi
colin
pathogenesi
pic
follow
extens
disrupt
epitheli
integr
widespread
airway
inflamm
bronchial
hyper
respons
cough
hypersensit
betz
et
al
cho
et
al
moric
zimmerman
et
al
studi
show
incid
cough
infect
increas
trend
recent
year
rais
rang
outbreak
atyp
pathogen
infect
ryan
et
al
although
littl
complex
pathogenesi
cough
reveal
human
best
increas
treatment
option
avail
moric
et
al
mani
patient
use
overthecount
drug
instanc
cough
suppress
expector
mucolyt
often
lack
clinic
proven
efficaci
activ
expens
unpleas
intoler
side
effect
two
class
cough
suppress
avail
central
action
codein
dextromethorphan
cloperastin
act
peripher
levodropropizin
expector
capabl
inhibit
cough
reflex
guaifenesin
meanwhil
common
side
effect
drug
nausea
dri
mouth
insomnia
dizzi
constip
anorexia
fatigu
sleepi
larg
part
incom
spent
treatment
cough
global
moric
howev
satisfactori
result
medicin
achiev
due
symptomat
treatment
side
effect
relaps
treatment
addit
montelukast
medica
gleam
treat
respiratori
tract
infect
unrespons
treatment
postinfecti
cough
therefor
unmet
need
exist
develop
effect
therapeut
approach
prevent
pic
alstonia
scholari
distribut
decidu
evergreen
forest
even
plain
wide
tropic
region
africa
asia
li
et
al
leav
long
use
dai
ethnopharmaci
treatment
whoop
cough
post
infecti
cough
chronic
bronchiti
asthma
respiratori
tract
infect
yunnan
provinc
pr
china
compil
group
yunnan
tradit
chines
medicin
phytochem
constitu
differ
part
plant
investig
intens
group
cai
et
al
cai
et
al
cai
et
al
cai
et
al
chen
et
al
du
et
al
du
et
al
feng
et
al
feng
et
al
liu
et
al
pan
et
al
qin
et
al
qin
et
al
xu
et
al
yang
et
al
yang
et
al
yang
et
al
yang
et
al
zhang
et
al
zhou
et
al
meanwhil
chemic
profil
metabolit
alkaloid
extract
scholari
report
cao
et
al
scholaricin
vallesamin
picrinin
major
indol
alkaloid
leaf
fig
pharmacokinet
behavior
rat
also
investig
zhao
et
al
moreov
scholari
extract
alkaloid
shown
antituss
antiasthmat
expector
shang
et
al
analges
antiinflammatori
shang
et
al
antiairway
inflamm
airway
antiallerg
effect
zhao
et
al
vivo
alkaloid
also
trigger
adrenerg
receptor
ar
activ
hou
et
al
inhibit
nuclear
hou
et
al
bioactiv
vitro
base
preclin
studi
total
indol
alkaloid
scholari
ta
regist
investig
new
botan
drug
approv
phase
iii
clinic
trial
china
food
drug
administr
cfda
phasei
singlecent
random
doubleblind
placebocontrol
clinic
trial
complet
result
support
phaseii
clinic
trial
tradit
use
pharmacolog
evalu
assum
alkaloid
leaf
scholari
might
use
treatment
respiratori
diseas
relat
airway
subacut
inflamm
paper
present
effect
alkaloid
model
postinfecti
cough
leav
scholari
collect
june
puer
citi
yunnan
provinc
peopl
republ
china
identifi
dr
xiaodong
luo
kunm
institut
botani
chines
academi
scienc
voucher
specimen
deposit
state
key
laboratori
phytochemistri
plant
resourc
west
china
chines
academi
scienc
dri
powder
leav
scholari
kg
extract
etoh
reflux
condit
h
solvent
evapor
vacuo
get
ethanol
extract
ethanol
extract
dissolv
aqueou
hcl
solut
filter
residu
recogn
nonalkaloid
fraction
acid
solut
adjust
ph
aqueou
ammonia
extract
etoac
give
ta
fraction
g
picrinin
vallesamin
sholaricin
isol
fig
kept
refriger
previou
phytochem
investig
ta
lipopolysaccharid
lp
purchas
sigmaaldrich
st
loui
mo
usa
hong
mei
brand
cigarett
purchas
hongta
tobacco
group
co
ltd
elisa
reagent
set
crp
purchas
r
system
minneapoli
mn
usa
malondialdehyd
mda
superoxid
dismutas
sod
determin
kit
purchas
jiancheng
bioengin
institut
nanj
jiangsu
china
chemic
solvent
highest
puriti
grade
avail
special
pathogenfre
male
icr
mice
weigh
approxim
g
purchas
kunm
medic
univers
licenc
number
syxk
anim
hous
room
temperatur
constant
humid
h
lightdark
cycl
spf
grade
laboratori
food
water
suppli
ad
libitum
anim
acclim
one
week
treatment
anim
studi
perform
accord
intern
rule
consid
anim
experi
intern
accept
ethic
principl
laboratori
anim
use
care
experi
perform
accord
previous
describ
method
modif
zhu
li
model
postinfecti
cough
mice
anesthet
intraperiton
inject
sodium
pentobarbit
trachea
intub
cannula
mm
length
outer
diamet
mm
mice
place
supin
posit
head
elev
use
micropipett
intraven
cathet
insert
intub
cannula
steril
salin
contain
lipopolysaccharid
correspond
vehicl
salin
instil
day
mice
except
control
place
smoke
chamber
challeng
exposur
smoke
cigarett
minday
total
day
day
intratrach
instil
mice
randomli
divid
group
treat
follow
control
group
receiv
intervent
model
group
carboxymethylcellulos
intragastr
ig
mlkg
dxm
dexamethason
ig
mg
kg
tah
total
indol
alkaloid
ig
mgkg
tam
total
indol
alkaloid
ig
mgkg
tal
total
indol
alkaloid
ig
mgkg
sch
scholaricin
ig
mgkg
epi
ig
mgkg
val
vallesamin
ig
mgkg
pic
picrinin
ig
mgkg
group
contain
ten
mice
schemat
diagram
treatment
schedul
shown
fig
day
anim
euthan
intraperiton
inject
sodium
pentobarbit
mgkg
overnight
food
depriv
blood
sampl
collect
via
orbit
vein
mice
serum
sampl
obtain
centrifug
blood
sampl
min
serum
sampl
prepar
store
analysi
crp
neumann
et
al
sod
mda
lemo
et
al
oper
perform
accord
manufactur
specif
right
lung
ligat
left
lung
lavag
ml
autoclav
pb
time
balf
immedi
centrifug
g
min
cell
pellet
resuspend
pb
total
cell
number
count
use
blood
count
instrument
wang
et
al
zheng
et
al
lung
tissu
supernat
prepar
describ
previous
tsai
et
al
balf
collect
mg
lung
homogen
ml
icecold
pb
assay
mixtur
cool
ice
follow
centrifug
g
min
obtain
supernat
store
requir
sod
mda
analysi
right
lung
tissu
embed
paraffin
cut
section
thick
stain
hematoxylin
eosin
h
e
evalu
gener
morpholog
report
previous
ichiki
et
al
degre
peribronchi
perivascular
inflamm
score
doubleblind
screen
two
independ
blind
investig
use
subject
scale
normal
lung
structur
lesion
bronchial
mucosa
alveolar
wall
mild
focal
lesion
bronchial
mucosa
alveolar
wall
structur
lesion
bronchial
mucosa
alveolar
wall
patchi
lesion
bronchial
mucosa
alveolar
wall
less
lobectomi
lesion
bronchial
mucosa
alveolar
wall
lobectomi
describ
elsewher
elagami
li
et
al
et
al
result
present
mean
sem
n
comparison
group
made
use
mannwhitney
test
multipl
comparison
made
use
anova
turkey
posttest
kruskal
walli
analysi
dunn
posttest
nonparametr
analys
appropri
p
valu
less
consid
signific
analys
contrast
control
mice
model
develop
cough
dyspnea
bristl
huddl
reduc
diet
reduct
weight
loss
administr
period
symptom
treatment
group
allevi
without
doserespons
depend
compar
model
group
lung
lavag
end
experi
differenti
cell
balf
count
investig
effect
ta
inflammatori
cell
influx
shown
tabl
number
wbc
p
vs
control
group
neutrophil
p
vs
control
group
balf
increas
mice
model
respect
number
wbc
tal
group
epi
group
p
vs
model
group
respect
number
neutrophil
three
ta
group
well
pic
group
crp
product
serum
analyz
elisa
shown
tabl
lp
instil
cs
significantli
increas
level
proinflammatori
cytokin
crp
serum
compar
model
anim
p
vs
control
group
respect
howev
tal
sch
group
significantli
reduc
level
respect
p
vs
model
group
content
crp
markedli
decreas
tah
tal
group
respect
dxm
group
show
similar
effect
two
paramet
p
vs
model
group
remain
treatment
group
trend
decreas
signific
differ
p
vs
model
group
oxid
stress
play
import
role
develop
pic
sod
mda
activ
serum
lung
homogen
determin
evalu
effect
indol
alkaloid
oxid
stress
shown
model
group
result
mark
declin
sod
activ
serum
homogen
tabl
compar
control
group
p
decreas
respect
encouragingli
tam
tal
group
significantli
promot
percentag
sod
activ
respect
serum
p
vs
control
group
p
vs
control
group
p
vs
control
group
lung
homogen
meanwhil
percentag
mda
content
serum
homogen
tabl
increas
p
vs
control
group
p
vs
control
group
model
group
tal
group
also
reduc
mda
level
two
sampl
p
vs
model
group
val
sch
decreas
content
mda
significantli
p
vs
model
group
pic
epi
show
improv
tendenc
p
vs
model
group
two
indic
compar
model
group
product
inflammatori
cell
lung
mice
also
investig
histopatholog
studi
lp
instil
cs
exposur
provoc
mice
mark
infiltr
neutrophil
around
peribronchi
perivascular
space
compar
normal
anim
fig
accordingli
score
total
lung
inflamm
increas
significantli
tabl
besid
bronchia
mucos
epithelium
appear
swell
shed
inflammatori
cell
infiltr
exud
airway
lumen
infiltr
neutrophil
bronchial
mucosa
observ
control
group
part
infiltr
neutrophil
granulocyt
observ
pulmonari
interstiti
around
peribronchovascular
result
indic
infiltr
inflammatori
cell
reduc
significantli
tatreat
mice
compar
lp
cs
challeng
mice
four
alkaloid
sch
epi
val
pic
also
prevent
infiltr
inflammatori
cell
tabl
product
total
leukocyt
balf
treatment
wbc
ml
neu
ml
note
data
express
mean
sem
statist
differ
repres
p
vs
control
p
p
vs
model
n
mice
per
group
crp
creactiv
protein
group
intragastr
administr
tabl
product
sod
serum
homogen
treatment
mean
sem
uml
note
data
express
mean
sem
statist
differ
repres
p
vs
control
p
p
vs
model
n
mice
per
group
sod
superoxid
dismutas
group
intragastr
administr
product
mda
serum
homogen
treatment
nmolml
control
model
dxm
tah
tam
tal
sch
epi
val
pic
note
data
express
mean
sem
statist
differ
repres
p
p
vs
control
p
p
vs
model
n
mice
per
group
mda
malondialdehyd
group
intragastr
administr
yl
zhao
et
al
journal
ethnopharmacolog
vari
degre
dxm
mgkg
treatment
use
refer
drug
improv
pulmonari
histolog
chang
remark
respiratori
tract
infect
varieti
bacteria
gram
posit
gram
neg
incid
pneumonia
much
higher
gramneg
infect
gramposit
infect
lipopolysaccharid
lp
larg
molecul
consist
lipid
polysaccharid
also
known
lipoglycan
endotoxin
found
outer
membran
gramneg
bacteria
stimul
strong
immun
respons
anim
may
caus
pic
inflammatori
respons
kitamura
et
al
salukjuszczak
wachowicz
sever
studi
shown
cigarett
smoke
impact
immun
function
respiratori
system
induc
recruit
inflammatori
cell
lung
releas
proinflammatori
cytokin
chemotact
factor
oxygen
radic
proteas
joad
et
al
karlsson
et
al
present
work
content
proinflammatori
cytokin
crp
lipid
peroxid
product
increas
significantli
yl
zhao
et
al
journal
ethnopharmacolog
besid
patholog
chang
lung
show
mani
inflammatori
cell
accumul
infiltr
success
anim
model
pic
establish
use
intratrach
instil
lp
cs
exposur
mice
sinc
etiolog
mechan
pic
extens
investig
number
experiment
model
neutrophil
key
blood
cell
play
import
role
pathogenesi
lung
inflamm
high
number
neutrophil
activ
reactiv
oxygen
system
aggrav
develop
respiratori
diseas
barn
cepkova
matthay
bronchoalveolar
lavag
fluid
balf
extens
util
evalu
alter
lung
microenviron
includ
pulmonari
epitheli
integr
cellular
damag
surfac
releaseaccumul
cellular
secretori
product
expect
anim
expos
lp
cs
exhibit
signific
increas
neutrophil
balf
consist
histolog
examin
lung
tissu
studi
treatment
indol
alkaloid
number
total
cell
neutrophil
balf
inhibit
meanwhil
lung
inflammatori
cell
infiltr
allevi
inflamm
control
variou
type
inflammatori
mediat
includ
cytokin
chemokin
associ
recruit
inflammatori
cell
tissu
destruct
liaudet
et
al
research
focus
examin
interleukin
creactiv
protein
crp
inflammatori
fibrogen
cytokin
thought
play
import
role
develop
lung
diseas
jasiewicz
et
al
recent
studi
demonstr
mark
increas
cs
expos
anim
crp
acutephas
protein
whose
elev
accompani
remark
pulmonari
inflamm
vo
et
al
clinic
trial
report
serum
crp
concentr
patient
copd
higher
healthi
control
de
torr
et
al
gan
et
al
investig
mice
intragastr
treat
indol
alkaloid
effect
suppress
elev
content
crp
produc
exposur
lp
cs
serum
except
control
group
result
suggest
modulatori
effect
proinflammatori
cytokin
may
one
mechan
defend
infect
report
cigarett
smoke
contain
mani
oxid
free
radic
caus
injuri
alveolar
epitheli
cell
reduc
antioxid
abil
lead
larg
number
protein
denatur
apoptosi
surround
tissu
induc
airway
inflamm
william
et
al
sod
enzym
exist
cell
remov
oxyrad
whose
activ
variat
may
repres
degre
tissu
injuri
extracellular
sod
might
modul
neutrophil
inflamm
reduc
cytokin
releas
macrophag
suggest
extracellular
sod
antiinflammatori
enzym
well
major
antioxid
mate
previou
studi
report
increas
mda
concentr
blood
balf
pulmonari
tissu
lp
administr
shen
et
al
also
observ
experi
current
studi
analyz
antioxid
paramet
sod
mda
serum
lung
tissu
found
sod
activ
rundown
significantli
lp
cs
treat
group
remark
recov
anim
treat
alkaloid
meanwhil
promot
mda
lp
cs
treat
anim
could
reduc
glucocorticoid
antiinflammatori
antiallerg
activ
potent
therapeut
agent
use
allevi
respiratori
failur
caus
neutrophil
granulocyt
alveolar
macrophag
metabol
activ
state
caramori
adcock
dexamethason
dxm
select
posit
control
alkaloid
treat
pic
result
indic
indol
alkaloid
leaf
alstonia
scholari
could
well
treat
pic
mice
roughli
equal
dxm
gener
p
vs
dxm
group
conclus
studi
display
indol
alkaloid
could
fight
pic
induc
lp
cs
exposur
howev
inhibit
effect
ta
appear
dosag
depend
manner
superior
singl
alkaloid
simultan
four
major
alkaloid
differ
effect
differ
indic
assum
synerg
effect
compon
may
compens
drawback
singl
compound
pic
importantli
effect
might
associ
reduct
inflammatori
infiltr
improv
oxid
antioxid
